Literature DB >> 2360827

In vitro tumor necrosis factor induction assay for analysis of febrile toxicity associated with amphotericin B preparations.

J K Chia1, E J McManus.   

Abstract

Amphotericin B can stimulate macrophages to produce tumor necrosis factor alpha (TNF alpha), one of the inflammatory mediators that may be responsible for the febrile toxicity associated with drug administration. The purpose of this study was to compare the in vitro TNF-inducing activity of one recalled lot of an amphotericin B preparation which was associated with more frequent febrile reactions in patients with a preparation not associated with a greater incidence of febrile reaction. We found that the former preparation induced significantly more TNF than the latter preparation, and the in vitro data correlated with the results of rabbit pyrogen testing. The in vitro TNF induction assay may serve as a screening tool for the selection of the least pyrogenic lots of amphotericin B preparation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2360827      PMCID: PMC171717          DOI: 10.1128/AAC.34.5.906

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Reducing amphotericin B reactions. A double-blind study.

Authors:  B S TYNES; J P UTZ; J E BENNETT; D W ALLING
Journal:  Am Rev Respir Dis       Date:  1963-02

2.  Amphotericin B induces tumor necrosis factor production by murine macrophages.

Authors:  J K Chia; M Pollack
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

3.  Purification and physico-chemical characterization of rabbit tumor necrosis factor.

Authors:  M R Ruff; G E Gifford
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

4.  Human leukocytic pyrogen test for detection of pyrogenic material in growth hormone produced by recombinant Escherichia coli.

Authors:  C A Dinarello; J V O'Connor; G LoPreste; R L Swift
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

5.  Amphotericin B fever in rabbits.

Authors:  J C Arroyo
Journal:  Life Sci       Date:  1984-03-26       Impact factor: 5.037

6.  Quantitation of amphotericins by reverse-phase high-performance liquid chromatography.

Authors:  M Margosis; A Aszalos
Journal:  J Pharm Sci       Date:  1984-06       Impact factor: 3.534

7.  Sensitive high-pressure liquid chromatographic assay for amphotericin B which incorporates an internal standard.

Authors:  G G Granich; G S Kobayashi; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  7 in total
  15 in total

1.  Interleukin-12 modulates the protective immune response in SCID mice infected with Histoplasma capsulatum.

Authors:  P Zhou; M C Sieve; R P Tewari; R A Seder
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

2.  Amphotericin B augments interleukin-6 production by human gingival fibroblasts in vitro.

Authors:  C A Lapp
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-09       Impact factor: 2.416

3.  Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.

Authors:  M Larabi; P Legrand; M Appel; S Gil; M Lepoivre; J Devissaguet; F Puisieux; G Barratt
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

4.  Analysis of tumor necrosis factor promoter responses to ultraviolet light.

Authors:  F Bazzoni; V Kruys; A Shakhov; C V Jongeneel; B Beutler
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

5.  Apoptosis contributes to amphotericin B-induced nephrotoxicity.

Authors:  D E Varlam; M M Siddiq; L A Parton; H Rüssmann
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

6.  Activities of naphthylisoquinoline alkaloids and synthetic analogs against Leishmania major.

Authors:  Alicia Ponte-Sucre; Johan H Faber; Tanja Gulder; Inga Kajahn; Sarah E H Pedersen; Martina Schultheis; Gerhard Bringmann; Heidrun Moll
Journal:  Antimicrob Agents Chemother       Date:  2006-11-06       Impact factor: 5.191

7.  Preincubation of Candida albicans strains with amphotericin B reduces tumor necrosis factor alpha and interleukin-6 release by human monocytes.

Authors:  G Raponi; M C Ghezzi; C Mancini; F Filadoro
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo.

Authors:  Y Tokuda; M Tsuji; M Yamazaki; S Kimura; S Abe; H Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

9.  Clinical evaluation of a new lipid-based delivery system for intravenous administration of amphotericin B.

Authors:  D Caillot; P Chavanet; O Casasnovas; E Solary; G Zanetta; M Buisson; O Wagner; B Cuisenier; A Bonnin; P Camerlynck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-08       Impact factor: 3.267

Review 10.  Optimizing efficacy of Amphotericin B through nanomodification.

Authors:  Gillian Barratt; Stéphane Bretagne
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.